Movement Disorders After Exposure to Antipsychotic Drugs in Patients With Depressive Disorders

Objectives The aims of the study were to explore the frequency of movement disorders (MDs) in depressive patients exposed to antipsychotic drugs (APDs) and to compare it with nonexposed depressive patients and APDs-treated schizophrenic patients. Methods Four hundred fifty-two depressive patients not exposed to APDs (group A), 156 depressives exposed to APDs (group B), and 75 patients with schizophrenia on APDs (group C) were recruited. Presence of MDs was explored by the Simpson-Angus and UKU scales (Registration: NCT02409823). Results Movement disorders were observed in 5%, 9%, and 13% of patients in groups A to C, respectively (P
Source: Clinical Neuropharmacology - Category: Neurology Tags: Original Articles Source Type: research